SCP Vitalife Partners

SCP Vitalife Partners operates as a venture capital firm, specializing in life science investments across Israel and the United States. The firm targets early to mid-stage companies with exceptional technology, proprietary advantages, and breakthrough products addressing significant medical needs. Its investment thesis emphasizes innovations protected by robust intellectual property for substantial impact within the global healthcare market.

Established in 2002, the firm was co-founded by individuals such as Wayne B. Weisman. The founding insight recognized Israel's significant potential as a life science technology hub, especially for medical devices. Partners capitalized on Israel's high rate of life-science patents-per-capita and its strong network within academia and the defense industry to build their strategy.

The firm's clientele consists of life science start-ups within its portfolio. SCP Vitalife Partners fosters these companies' growth by providing hands-on assistance and leveraging established strategic partner relationships. Their vision is to cultivate successful enterprises that capitalize on major market trends and introduce innovative solutions to critical medical challenges.